Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-103166

Chief Dev. & Ops. Officer bought 220 shares at $7.87 ($1,731)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shemesh Shay Chief Dev. & Ops. Officer 2022-09-23 Purchase +220 $7.87 $1,731 1,245,065 D
Open-market purchases · 220 sh · avg $7.87 · $1,731
Loading xslF345X03/tm2226689-2_4seq1.xml…